Fulgent Genetics Announces Launch of Next Generation Sequencing (NGS) Test to Detect Coronavirus Disease (COVID-19)

Stock Information for Fulgent Genetics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Fulgent Genetics Inc.

Fulgent Genetics Set to Join S&P SmallCap 600
Fulgent Genetics to Provide COVID-19 Testing Solutions for the State of Utah
Fulgent Genetics, Miami-Dade County Partner on COVID-19 testing
Fulgent Genetics to Participate in the H.C. Wainwright 22nd Annual Global Investment Conference
Fulgent Genetics Adds Influenza A and Influenza B to all COVID-19 Tests
Fulgent Genetics, New York City Health and Hospitals Partner on Large-Scale Back-to-School COVID-19 Testing
Fulgent Genetics Announces Expansion into Houston, TX
Fulgent Genetics Reports Record Second Quarter 2020 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.